We tested the effect of the cardioactive peptide Urocortin 2 (Ucn2; 100 nM) on action potential (AP)-induced Ca transients (CaT), sarcoplasmic reticulum (SR) Ca load and cardiac Ca alternans. Experiments were performed on single rabbit atrial and ventricular myocytes from normal and failing hearts. Chronic heart failure (HF) was induced by combined pressure-and volume-overload. Ca and mechanical alternans was induced by electrical pacing. Changes in cytosolic [Ca]i and [Ca]SR were monitored with fluorescent indicators, in conjunction with sarcomere length measurements. The average Ca alternans ratio (AR ¼ 1-S/L; S: small amplitude CaT; L: large-amplitude CaT) was 0.51 in normal atrial myocytes, and 0.43 and 0.53 in normal and HF ventricular myocytes, respectively. Ucn2 increased SR Ca load in normal, and to a larger degree in HF ventricular cells, and enhanced AP-induced SR Ca depletion transients. Baseline phosphorylation levels of phospholamban (PLN) at Ser16 were increased in HF myocytes, and Ucn2 stimulation further augmented PLN phosphorylation in normal myocytes (~10-fold) and to a lesser extent (~5-fold) in HF ventricular myocytes. Ucn2 completely abolished Ca and mechanical alternans (within 2-3 min) in normal atrial as well as in normal and HF ventricular myocytes. In the presence of Astressin-2B (1 mM; inhibition of corticotropin-releasing factor receptor; CRFR2) and H89 (1 mM; protein kinase A inhibition) Ucn2 failed to rescue alternans. In conclusion, we propose that Ucn2 rescues cardiac alternans via CRFR2-mediated stimulation of PKA, phosphorylation of PLN and enhanced cytosolic Ca sequestration by SERCA. Spontaneous calcium (Ca) release in cardiac myocytes can produce delayed afterdepolarizations (DADs) that promote arrhythmias. In these studies, we combined experimental and computational approaches to investigate quantitatively how Ca release features at subcellular, cellular, and tissue scales influence DADs. Spontaneous Ca release events and corresponding DADs were measured experimentally from isolated rabbit ventricular myocytes exposed to elevated extracellular Ca (2.7 mM) and isoproterenol (0.25 mM), and were compared between lower and higher total intracellular Ca levels following 1 or 5 paced beats at 400 ms intervals, respectively. At the subcellular scale, Ca waves emerged simultaneously from an average of 1.36 (low) and 2.5 (high) sites per Ca release event. Consistent with the criticality-based theory of Ca wave emergence, Ca wave numbers were proportional to sarcoplasmic reticulum (SR) Ca levels that produced INCX with À71.1 pA/pFÂms (low) and À106.0 pA/pFÂms (high) integrated current densities upon rapid exposure to caffeine (10 mM). At the cellular scale, whole-cell calcium transients had peak amplitudes of 0.462 F/Fo (low) and 0.717 F/Fo (high) and full widths at half maximum (FWHMs) of 309.0 ms (low) and 180.0 ms (high). Resultant DADs had peak amplitudes of 1.41 mV (low) and 6.03 mV (high) and FWHMs of 302.3 ms (low) and 140.3 ms (high). Ca wave latencies in single myocytes, which determine Ca release synchrony in cardiac tissue, were 0.996 s (low) and 0.416 s (high). Computer simulation analyses implementing various combinations of the experimentally measured factors suggest that greater numbers of Ca waves, increased SR Ca release, and greater synchrony are associated with larger DAD amplitudes in cardiac tissue. Simulations also suggest that the subcellular number of Ca waves has the largest impact on DAD amplitude in tissue. Using fluorescence resonance energy transfer (FRET), we directly tested the hypothesis that S100A1 competes with calmodulin (CaM) for binding to intact, functional ryanodine receptors type I (RyR1) and II (RyR2) from skeletal and cardiac muscle, respectively. This hypothesis is largely based on competition assays using isolated sarcoplasmic reticulum (SR) membranes from skeletal muscle and evidence that S100A1 binds to peptides corresponding to one of the proposed CaM binding domains on RyR1. However, competition between S100A1 and CaM for RyR binding has not been directly detected. We targeted a donor-labeled FKBP12.6 (D-FKBP) to the cytoplasmic domain of RyR1 or RyR2 in SR vesicles isolated from pig skeletal or cardiac muscle. FRET was detected as a decrease of D-FKBP fluorescence in the presence of 100nM acceptor-labeled CaM (A-CaM) and used to index CaM binding to RyR. Upon pre-incubating SR with [S100A1] ranging from 0.01 to >100 mM, we found partial inhibition of FRET, with mM K I , for both skeletal and cardiac SR. By comparison, FRET was completely inhibited by unlabeled WT-CaM (K I~1 00nM), indicating that A-CaM and WT-CaM bind RyR with similar affinities and at the same site. Similar results were obtained using co-sedimentation assays conducted under similar experimental conditions, to detect competition between S100A1 and CaM binding to SR membranes. Taken together, these results indicate that CaM-RyR binding may not be significantly competed by S100A1 under normal physiologic conditions. Furthermore, structural analysis of FRET data suggests that S100A1 allosterically interacts with RyRCaM binding. Initial results from a complementary FRET approach, using acceptor-labeled S100A1, further support the conclusion that S100A1 does not significantly compete with CaM-RyR binding in skeletal or cardiac muscle.
Background: Loss of function mutations in hERG potassium channels underlie the long QT syndrome type 2 (LQT2). LQT2 is associated with fatal ventricular arrhythmias promoted by triggered activity in the form of early afterdepolarizations (EADs). However, the cellular mechanism of EAD formation remains unexplored. Spontaneous calcium (Ca) release in cardiac myocytes can produce delayed afterdepolarizations (DADs) that promote arrhythmias. In these studies, we combined experimental and computational approaches to investigate quantitatively how Ca release features at subcellular, cellular, and tissue scales influence DADs. Spontaneous Ca release events and corresponding DADs were measured experimentally from isolated rabbit ventricular myocytes exposed to elevated extracellular Ca (2.7 mM) and isoproterenol (0.25 mM), and were compared between lower and higher total intracellular Ca levels following 1 or 5 paced beats at 400 ms intervals, respectively. At the subcellular scale, Ca waves emerged simultaneously from an average of 1.36 (low) and 2.5 (high) sites per Ca release event. Consistent with the criticality-based theory of Ca wave emergence, Ca wave numbers were proportional to sarcoplasmic reticulum (SR) Ca levels that produced INCX with À71.1 pA/pFÂms (low) and À106.0 pA/pFÂms (high) integrated current densities upon rapid exposure to caffeine (10 mM). At the cellular scale, whole-cell calcium transients had peak amplitudes of 0.462 F/Fo (low) and 0.717 F/Fo (high) and full widths at half maximum (FWHMs) of 309.0 ms (low) and 180.0 ms (high). Resultant DADs had peak amplitudes of 1.41 mV (low) and 6.03 mV (high) and FWHMs of 302.3 ms (low) and 140.3 ms (high). Ca wave latencies in single myocytes, which determine Ca release synchrony in cardiac tissue, were 0.996 s (low) and 0.416 s (high). Computer simulation analyses implementing various combinations of the experimentally measured factors suggest that greater numbers of Ca waves, increased SR Ca release, and greater synchrony are associated with larger DAD amplitudes in cardiac tissue. Simulations also suggest that the subcellular number of Ca waves has the largest impact on DAD amplitude in tissue.
